Cover Image

Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance

Despite the initial benefit from treating ERBB2-positive breast cancer with tyrosine kinase inhibitor lapatinib, resistance develops inevitably. Since the expression of protein tyrosine phosphatase receptor-type O (PTPRO), a member of the R3 subfamily of receptor protein tyrosine phosphatases (PTPs)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hongmei Dong (Author), Liang Du (Author), Songwang Cai (Author), Wan Lin (Author), Chaoying Chen (Author), Matthew Still (Author), Zhimeng Yao (Author), Robert P. Coppes (Author), Yunlong Pan (Author), Dianzheng Zhang (Author), Shegan Gao (Author), Hao Zhang (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

From Tyrosine Kinases to Tyrosine Phosphatases: New Therapeutic Targets in Cancers and Beyond
by: Yu Zhou, et al.
Published: (2024)

Comprehensively Analyze the Prognosis Significance and Immune Implication of PTPRO in Lung Adenocarcinoma
by: Zhimin Lin, et al.
Published: (2023)

Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases
by: Ao Wang, et al.
Published: (2024)

New natural protein tyrosine phosphatase 1B inhibitors from Gynostemma pentaphyllum
by: Xianting Wang, et al.
Published: (2024)

Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with Protein Tyrosine Phosphatase Non-Receptor Type 11 Gene Mutation
by: Huang R, et al.
Published: (2023)

Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
by: Quan Liang, et al.
Published: (2016)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
by: Zhendong Song, et al.
Published: (2021)

Tyrosine Kinases and Phosphatases: Enablers of the Porphyromonas gingivalis Lifestyle
by: Richard J. Lamont, et al.
Published: (2022)

Voltage sensitive phosphatases: emerging kinship to protein tyrosine phosphatases from structure-function research
by: Kirstin eHobiger, et al.
Published: (2015)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
by: M.Saadat, et al.
Published: (1998)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
by: M.Saadat, et al.
Published: (1998)

Druggability analysis and classification of protein tyrosine phosphatase active sites
by: Ghattas MA, et al.
Published: (2016)

The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases
by: Peyton High, et al.
Published: (2024)

New dammarane-type triterpenoids from hydrolyzate of total Gynostemma pentaphyllum saponins with protein tyrosine phosphatase 1B inhibitory activity
by: Daopeng Tan, et al.
Published: (2023)

Proto-oncogene c-erbB2 initiates rat primordial follicle growth via PKC and MAPK pathways
by: Xiao-Yu Du, et al.
Published: (2010)

Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
by: Min Ye, et al.
Published: (2021)

Citric Acid Controls the Activity of YopH Bacterial Tyrosine Phosphatase
by: Styszko J, et al.
Published: (2024)

Lapatinib-induced acute generalized exanthematous pustulosis
by: Chembolli Lakshmi, et al.
Published: (2010)

Study on the Relationship Between PTPRO Methylation in Plasma and Efficacy Neoadjuvant Chemotherapy in Patients with Early Breast Cancer
by: Liu XW, et al.
Published: (2023)

Dual-Specificity Phosphatases and Kidney Diseases
by: Haiyang Li, et al.
Published: (2021)

Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors
by: Ningbo Qin, et al.
Published: (2018)

High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma
by: Muntinee Lertpanprom, et al.
Published: (2022)

Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression
by: Xiao Li, et al.
Published: (2023)

Bacterial Protein Tyrosine Phosphatases as Possible Targets for Antimicrobial Therapies in Response to Antibiotic Resistance
by: Alicja Kuban-Jankowska, et al.
Published: (2022)

Evaluation of the Hypoglycemic Activity of Morchella conica by Targeting Protein Tyrosine Phosphatase 1B
by: Naeema Begum, et al.
Published: (2021)

A pan-cancer analysis of oncogenic protein tyrosine phosphatase subfamily PTP4As
by: Mingyang Yu, et al.
Published: (2023)

Screening and Identification of Key Biomarkers in Acquired Lapatinib-Resistant Breast Cancer
by: Shengnan Bao, et al.
Published: (2020)

MiR-6869-5p Induces M2 Polarization by Regulating PTPRO in Gestational Diabetes Mellitus
by: Pingping Wang, et al.
Published: (2021)

Different chemical proteomic approaches to identify the targets of lapatinib
by: Tatjana Kovačević, et al.
Published: (2023)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011)

Targeting HER 1 and 2 in breast cancer with lapatinib
by: Gerald M. Higa
Published: (2011)

SH2 domain‐containing protein tyrosine phosphatase‐2 is enriched in eyelid specimens of rosacea
by: Apoorv Chebolu, et al.
Published: (2023)

Detection of a Tyrosine Phosphatase LAR on Intestinal Epithelial Cells and Intraepithelial Lymphocytes in the Human Duodenum
by: Anne M. Murphy, et al.
Published: (2005)

Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis
by: Águeda González-Rodríguez, et al.
Published: (2018)

Virtual Screening and Biological Evaluation of Novel Low Molecular Weight Protein Tyrosine Phosphatase Inhibitor for the Treatment of Insulin Resistance
by: Feng B, et al.
Published: (2023)

The ErbB1-dependent effect of recombinant epidermal growth factor (rEGF) against lapatinib-induced cytotoxicity in Caco-2 human intestinal cells / Raja Nur Firzanah Syaza Raja Sharin ... [et al.]
by: Raja Sharin, Raja Nur Firzanah Syaza, et al.
Published: (2022)

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
by: Hao Wang, et al.
Published: (2022)

HER2 (ERBB2) alterations in colorectal cancers
by: Nika Tavberidze, et al.
Published: (2022)

Clinical Trials Focusing on Drug Control and Prevention of Ventilator-Associated Pneumonia: A Comprehensive Analysis of Trials Registered on ClinicalTrials.gov
by: Lingmin Chen, et al.
Published: (2019)

Em08red, a dual functional antiproliferative emodin analogue, is a downregulator of ErbB2 expression and inducer of intracellular oxidative stress
by: Liang FP, et al.
Published: (2015)